VC firm
the Retinal Degeneration Fund
- Investor type
- VC
- Investing status
- Activeas of 2026-09-22Source (opens in a new tab)
- Founded
- 2018
- Assets under management
- $140MStated by firm, as of 2026-09-22Source (opens in a new tab)
- Check size
- $1M to $5MSource (opens in a new tab)
- gundvisionfund.org (opens in a new tab)
- LinkedIn (opens in a new tab)
- X (opens in a new tab)
- Team page (opens in a new tab)
Claim, correct or request removal
Record updated 30 September 2026
About
The Gund Vision Fund, formerly the Retinal Degeneration Fund (RD Fund), is the venture philanthropy arm of the Foundation Fighting Blindness and a 501(c)(3) not-for-profit subsidiary.
Investment approach
- Thesis
- Venture philanthropy puts donated capital to work like an investment, deploying it strategically to advance the mission of a nonprofit. The Gund Vision Fund bridges the critical funding gap between discovery-stage research and drug development, making targeted investments in companies with the greatest potential to deliver treatments for inherited retinal diseases and dry AMD.Source (opens in a new tab)
- Reserves policy
- with up to $10 to $15 million in follow-on reserves
- Eligibility
- Focuses primarily on companies with programs that are in clinical testing or can be in less than 18 to 24 months
- Traction requirement
- primarily on companies with programs that are in clinical testing or can be in less than 18 to 24 months
- Investing status notes
- Partner With Us
Loading relationship preview